7:00 – 7:50Registration, Continental Breakfast and Exhibitor Showcase
Morning Sessions
7:50 – 8:00Welcome and Opening Remarks
Michael Gonyeau, PharmD, Interim Dean of the School of Pharmacy and Pharmaceutical Sciences, and John Devlin, PharmD, BCCPS, MCCM, Professor, School of Pharmacy and Pharmaceutical Sciences.
2025 SCCM Pain, Agitation, Delirium, Immobility and Sleep Disruption Practice Guideline Update
8:00 – 8:30Sedative Choice: The Role of Dexmedetomidine vs. Alternative Agents
Joanna Stollings, PharmD, BCCPS, FCCM, Vanderbilt University Medical Center, Nashville, TN 
8:30 – 9:00Pharmacologic Sleep Improvement: The Role of Melatonin Analogs
Gerald Weinhouse, MD, Brigham and Women’s Hospital, Boston, MA
9:00 – 10:00Medical AI: Augmented intelligence Vs. Arrested intelligence
Raja-Elie Abdulnour, MD, Brigham and Women’s Hospital, Boston, MA
10:00 –10:30Break AND EXHIBITOR SHOWCASE
10:30 – 11:15MORNING PEARLS (10 PGY-2 Critical Care Residents)
11:15 – 11:45Treatment of Hyperglycemic Crises: A 2025 ADA Guideline Update
Oussayma Moukhachen, PharmD, BCPS, BCCCP, Massachusetts College of Pharmacy and Health Sciences, Boston, MA and Mt. Auburn Hospital, Cambridge, MA
11:45 – 12:15Management of Anxiety in the ICU
Maureen K. Cassady, MD, Brigham and Women’s Hospital, Boston, MA
12:15 – 1:15Lunch and Exhibitor Showcase
Afternoon Sessions
1:15 – 2:15Current ARDS Controversies: Ventilator Strategies, Sedation Management and Neuromuscular Blocker Use/Monitoring
Rachel Winner, PharmD, BCCPS, and Rachel Putman, MD, Brigham and Women’s Hospital, Boston, MA
2:15 –2:45 Anticoagulant Reversal:  Current Controversies
Andrew Webb, PharmD, BCCPS, Massachusetts General Hospital, Boston, MA
2:45- 3:00  Break AND EXHIBITOR SHOWCASE
3:00 – 3:30AFTERNOON PEARLS (7 PGY-2 Critical Care Residents)
3:30 – 4:00   Interpretation of ICU Studies Employing Target Trial Emulation 
Ting Ting Wu, PharmD, PhD, BCCCP, Harvard Pilgrim Healthcare Institute, Boston, MA
4:00 – 4:15PROGRAM Wrap Up